Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,096.00
Bid: 12,088.00
Ask: 12,092.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.033%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,096.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Spain approves AstraZeneca COVID-19 vaccine for 18-55 year-olds

Fri, 05th Feb 2021 17:38

(Recasts to lead with vaccine approval)

MADRID, Feb 5 (Reuters) - Spain approved AstraZeneca's
coronavirus vaccine for use in people aged 18 to 55 on
Friday, becoming the latest country to limit the shot to younger
people due to a lack of data on its use among the elderly.

Italy also recommends its preferential use for adults of 55
and under, while Germany, France, Austria and Norway will only
administer the shot to people younger than 65.

Separately, Madrid confirmed on Friday the region's first
case of the Brazilian COVID-19 variant, while the national
health ministry said it was not aware of any other cases of the
highly contagious strain on Spanish territory.

Catalan authorities announced Spain's second known case of
the South African variant on Wednesday, a day after the
government restricted air travel with Brazil and South Africa to
curb the spread of the virulent new strains from those
countries.

A third wave of COVID-19 infections has been slowing, with
Spain's 14-day incidence rate falling to 751 cases per 100,000
people on Friday from 900 cases in late January, but officials
say the arrival of the new strains could drive a resurgence.

The health ministry recorded 28,565 new cases on Friday,
bringing the total above 2.94 million, while the death toll
climbed by 584 to 61,386.

"IT'S VERY CONFUSING"

In an initial phase aimed at protecting care-home residents
and workers and front-line medics, Spain has administered 1.87
million doses produced by Pfizer and Moderna.

It expects a delivery of 1.8 million AstraZeneca doses in
February to speed up the pace of inoculation and help it hit a
target of vaccinating 70% of the population by summer.

Nearly three quarters of Spaniards are willing to receive a
shot as soon as one became available, according to a poll by the
Centre for Sociological Studies (CIS) but some remain wary.

"At the moment I will not get one. I will wait a bit," said
80-year old retired lawyer Livigno, out walking in central
Madrid. "You hear positive and negative comments and it's very
confusing. I am not even sure the government is clear."

In one rare bit of good news from the COVID frontline, two
patients recovering from the virus, Fernando, 70, and Rosario,
62, got married at Madrid's Hospital Isabel Zendal after he
proposed to her via WhatsApp. They were married by a priest via
videolink.

(Reporting by Nathan Allen and Graham Keeley
Editing by Ingrid Melander and Gareth Jones)

More News
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.